July 2010 Editor's Picks: Products from Gems Sensors and Controls and Telstar - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

July 2010 Editor's Picks: Products from Gems Sensors and Controls and Telstar

Equipment and Processing Report

Featured products from Pharmaceutical Technology's monthly newsletter, Equipment & Processing Report

product Gems Sensors and Controls
Flow sensors offer visual indication

The RotorFlow RFO fluid-flow sensors from Gems Sensors and Controls (Plainville, CT) provide a pulsed 4.5–24-V output that is proportional to the rate of flow. The direct-current output can be integrated into most digital logic units easily. The sensors include a highly visible paddlewheel that provides verification that fluids are moving.

As liquid passes through the unit’s body, a magnetic rotor spins at a rate proportional to the flow rate. The magnetic fields turning with the rotor excite a static Hall Effect sensor located in the body and generate a series of voltage pulses. Digital rate meters, totalizers, and other electronic controllers then use the output signal.

The RotorFlow sensors are available in port sizes of 0.25 to 1 in. and monitor fluids with flow rates ranging from 0.1 to 60 GPM. The units are appropriate for applications such as water purification, dispensing systems, chemical metering, and chillers and heat exchangers.


productTelstar
Biosafety cabinet protects operators

Telstar’s (Terrassa, Spain) CytoUltra biosafety cabinet is designed to protect operators from cytotoxic and hazardous products that contain small amounts of volatile chemicals. The unit produces laminar airflow and incorporates three stages of high-efficiency particulate-air filtration. Operators control the device through microprocessor electronics. The unit has two independent controls with dedicated fans for the laminar flow and the exhaust fan, each of which is regulated by a dedicated speed probe. The cabinet’s sash is a 20-cm opening, and its sloped glass door is moved electronically.

The unit’s dedicated fan creates an inflow of more than 0.5 m/s. The inflow speed and laminar flow can be adjusted to different set points if required. The inflow and the device’s multistage filtration help shield operators from hazardous materials. Testing has shown that the CytoUltra device protects operators from 20-nm particles. The cabinet is appropriate for pharmaceutical manufacturing processes.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
18%
To all process for new products only
13%
To select process for new products only
22%
To select processes for both new and legacy products
22%
Do not use QbD
24%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search
Source: Equipment and Processing Report,
Click here